Rimiducid
bellicum pharma,regeneron
['prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'regeneron', 'immune therap', 'bellicum']
busy day at #gu23. presented two novel immune therapy trials -cd28xpsma bispecific antibody by regeneron and a psca car-t by bellicum - both studies had some subjects with deep psa responses. dawn of a new era of immune therapy in prostate cancer. 